Music-Based Relaxation for Anxiety in Young Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a music-based relaxation program called TiMBRe, designed to reduce anxiety in young cancer survivors. The program lasts eight weeks and includes virtual music sessions tailored to each participant. Half of the participants will try TiMBRe, while the other half will receive standard care, such as calls and resources. It suits individuals aged 15-39 who completed cancer treatment at least a month ago and have recently experienced anxiety. As an unphased trial, this study provides a unique opportunity to explore innovative anxiety-reduction methods tailored to participants' needs.
Do I need to stop my current medications for this trial?
You can continue your current anxiety medications if you started them at least eight weeks before joining the study and haven't changed the dose. If you're planning to start new treatments for anxiety, you can't join the trial.
What prior data suggests that this music-based relaxation intervention is safe for young cancer survivors?
Research has shown that music-based relaxation methods, such as the TiMBRe program, are generally safe. Studies have found that similar music therapy during chemotherapy can reduce anxiety and improve well-being without causing harm. Because music-based treatments don't involve drugs, they avoid medication-related side effects. Participants in past studies reported feeling more relaxed and less anxious after these sessions. While TiMBRe is still under evaluation, it is designed to be well-tolerated, focusing on relaxation and stress relief through gentle, non-invasive music.12345
Why are researchers excited about this trial?
Unlike standard treatments for anxiety in young cancer survivors that might include medications or therapy, TiMBRe offers a unique approach through music-based relaxation. This eight-week program is delivered virtually, making it highly accessible regardless of location. Researchers are excited about TiMBRe because it is tailored to individual needs, potentially enhancing its effectiveness in reducing anxiety. Additionally, its non-invasive nature and the comfort of engaging with music could make it a more appealing option for young people.
What evidence suggests that the TiMBRe intervention might be an effective treatment for anxiety?
Research has shown that music-based relaxation techniques can reduce anxiety in young cancer survivors. In this trial, the TiMBRe treatment, which participants may receive, uses music specifically designed to help them relax and feel less anxious. Although limited data exists on TiMBRe's effectiveness, music therapy has shown promise in similar situations for reducing anxiety. This method focuses on calming elements like tone and rhythm. The aim is to provide a soothing experience that may ease the anxiety often felt by young cancer survivors.12567
Who Is on the Research Team?
Robert Knoerl
Principal Investigator
University of Michigan Rogel Cancer Center
Are You a Good Fit for This Trial?
This trial is for young cancer survivors aged 15-39 who have finished cancer treatment at least a month ago and are experiencing significant anxiety. Participants must be able to speak and read English, and they should score ≥55 on the PROMIS Anxiety 4a scale indicating notable anxiety levels.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive an eight-week, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety
Follow-up
Participants are monitored for changes in anxiety and other outcomes after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Control
- TiMBRe
Trial Overview
The study is testing an eight-week virtual program called TiMBRe, which involves tailored music-based relaxation sessions lasting 45 minutes each week, aimed at reducing anxiety in adolescent and young adult cancer survivors.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in AYA cancer survivors with clinically-relevant anxiety.
Standard of care study staff calls and cancer survivorship resources
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan Rogel Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Published Research Related to This Trial
Citations
Determining the Feasibility of Virtual Tailored, Music-Based ...
Abstract Text. Clinical Problem: Up to 48.5% of adolescent and young adult (AYA, 15 – 39 years old) cancer survivors experience clinically relevant anxiety.
Feasibility of Virtual, Tailored, Music-Based Relaxation for ...
Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors · Study Overview · Contacts and Locations.
Funded Grants | Division of Cancer Prevention
Clinical Problem: Up to 48.5% of adolescent and young adult (AYA, 15 – 39 years old) cancer survivors experience clinically relevant anxiety.
Music-Based Relaxation for Anxiety in Young Cancer ...
TiMBRe is unique because it uses music-based relaxation specifically designed to reduce anxiety in young cancer survivors, focusing on elements like tone, ...
Project Details
Clinical Problem: Up to 48.5% of adolescent and young adult (AYA, 15 – 39 years old) cancer survivors experience clinically relevant anxiety.
Feasibility of Virtual, Tailored, Music-Based Relaxation for ...
... music-based relaxation (TiMBRe) intervention to decrease anxiety in adolescent and young adult (AYA) cancer survivors with clinically-relevant anxiety.
Effect of group music therapy on state-anxiety and well-being ...
The results suggest that group music therapy during chemotherapy is a safe and effective strategy to improve mental health and well-being in ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.